Viewing nowCombinationTelmiroget Tablets 40/20/10 mg
Rosuvastatin Calcium Micronized 20.8mg · Ezetimibe 10mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 202202207 · Approved 2022.05.24 · Insurance code 643308990
Treatment of essential hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease
This medication is used for patients who need to take Telmisartan along with Rosuvastatin/Ezetimibe simultaneously. Telmisartan helps treat essential hypertension and reduces the risk of myocardial infarction, stroke, and cardiovascular mortality in patients over 55 years of age at high risk of major cardiovascular events. It is especially suitable for patients who cannot use ACE inhibitors. Meanwhile, Rosuvastatin/Ezetimibe is used to improve blood cholesterol and lipid levels in patients with primary hypercholesterolemia and dyslipidemia. This combination lowers total cholesterol and bad cholesterol (LDL), ApoB, and triglyceride levels while increasing good cholesterol (HDL). Therefore, this medication effectively improves cardiovascular health through blood pressure and lipid management.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of telmisartan and the rosuvastatin/ezetimibe combination. Take 1 tablet once daily with water, with or without food. If possible, it is recommended that the medicine be taken at the same time each day (e.g., in the morning). ○ Telmisartan 1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When telmisartan is administered concomitantly with thiazide diuretics such as hydrochlorothiazide, it provides an additional blood pressure-lowering effect. Following a dose increase, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of telmisartan is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is not known. When initiating telmisartan treatment to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ∘ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed telmisartan 40 mg once daily. ○ Rosuvastatin/ezetimibe The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. The dose may be adjusted in patients who require a greater reduction in LDL-cholesterol. After starting treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of 4 weeks or longer and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. Patients taking telmisartan and the rosuvastatin/ezetimibe combination concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Severe muscle problems may occur, and if symptoms such as acute myalgia or myopathy arise, it is necessary to consult a physician immediately. Patients with severely impaired liver function or active liver disease should not take this medication. Patients with severely impaired kidney function should also not take this medication, and particularly, diabetic patients with compromised kidney function should avoid combination therapy. Patients with a history of muscle disease or at high risk for muscle damage should use this medication cautiously and report any muscle-related symptoms immediately to healthcare personnel. As this medication lowers blood pressure, symptoms of hypotension or dizziness may occur, so caution is needed while driving or operating machinery. This medication can increase potassium levels in the blood, so patients at risk for hyperkalemia should receive regular blood tests. Since this medication can interact with other drugs, particularly if taking antihypertensives, diuretics, anticoagulants, etc., it is essential to inform the physician. If any adverse symptoms like liver dysfunction, myalgia, severe skin rash, or breathing difficulties occur, stop the medication immediately and visit a hospital. It should be used along with a proper diet, and regular liver and kidney function tests should be performed before and during treatment. This medication contains lactose, so it should not be taken by patients with lactose intolerance. Women of childbearing age should use appropriate contraception methods to prevent pregnancy while taking this medication.
Gastritis, gastroesophageal reflux disease, hemorrhoids, colonic polyps, vomiting, headache, increased ALT, increased AST, chest pain, facial swelling, abnormal sensation, drug intolerance, irritable bowel syndrome, esophagitis, dizziness, drowsiness, neurodegenerative disorders, positional dizziness, migraine, diabetes, glucose load impairment, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, sweating, dermatitis, skin burning, skin disorders, alopecia, oropharyngeal pain, nasal obstruction, respiratory distress, pelvic pain, breast cysts, drooping eyelids, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, headache, facial spasms, sensory disturbances, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, arrhythmia, weakness, edema, decreased libido, facial swelling, rash, alopecia, conjunctivitis, tinnitus, petechiae, increased ALT, myalgia, increased CK, dizziness, constipation, increased AST, myasthenia, joint pain, fatigue, numbness, sensory disturbances, chest discomfort, nausea, abdominal pain, diarrhea, loss of appetite, abdominal bloating, itching, fainting, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine, vascular edema, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, fainting, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal fullness, abdominal discomfort, dry mouth, liver function abnormalities, hepatic disorders, increased sweating, itching, rash, erythema, vascular edema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, joint pain, limb pain, tendon pain, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, increased liver enzymes, elevated creatine kinase, decreased hemoglobin, palpitations, fatigue, nausea, insufficient effect, facial spasms, sensory disturbances, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, arrhythmia, weakness, edema, decreased libido, facial swelling, rash, alopecia, conjunctivitis, tinnitus, petechiae, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, joint pain, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, memory decline, forgetfulness, amnesic syndrome, memory impairment, confusion, severe muscle weakness, ocular myasthenia, fatigue, chest pain, discomfort in the chest, edema, weakness, generalized edema, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disturbance, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, runny nose, limb pain, joint pain, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, rash, itching, upper respiratory infection, conjunctival hyperemia, renal failure, liver function abnormalities, increased serum creatinine, hypertension, increased serum urea, increased CPK, liver function test abnormalities
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. Storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature. This will help maintain the drug's effectiveness and safety for an extended period.
Brown oval film-coated tablet
30 tablets/bottle, 3 tablets/bottle, 10 tablets/PTP, 30 tablets/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium Micronized 20.8mg · Ezetimibe 10mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium Micronized 10.4mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium Micronized 5.2mg +1 more
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.